EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chemical Modification of Tiopronin for Dual Management of Cystinuria and Associated Bacterial Infections

Anil Kumar, Lori M Estes Bright, Mark Richard Stephen Garren iD, James Manuel, Arpita Shome, Hitesh Handa iD

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c07160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Anil Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Materials and Biomedical Engineering, University of Georgia, Athens, Georgia 30602, United States. Hauptthemen laut MEDLINE: Cystinuria, Bacterial Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystinuria is an inherited autosomal recessive disease of the kidneys of recurring nature that contributes to frequent urinary tract infections due to bacterial growth and biofilm formation surrounding the stone microenvironment. In the past, commonly used strategies for managing cystinuria involved the use of (a) cystine crystal growth inhibitors such as l-cystine dimethyl ester and lipoic acid, and (b) thiol-based small molecules such as N-(2-mercaptopropionyl) glycine, commonly known as tiopronin, that reduce the formation of cystine crystals by reacting with excess cystine and generating more soluble disulfide compounds. However, there is a dearth of simplistic chemical approaches that have focused on the dual treatment of cystinuria and the associated microbial infections. This work strategically exploited a single chemical approach to develop a nitric oxide (NO)-releasing therapeutic compound, S-nitroso-2-mercaptopropionyl glycine (tiopronin-NO), for the dual management of cystine stone formation and the related bacterial infections. The results successfully demonstrated that (a) the antibacterial activity of NO rendered tiopronin-NO effective against the stone microenvironment inhabitants, Escherichia coli and Pseudomonas aeruginosa, and (b) tiopronin-NO retained the ability to undergo disulfide exchange with cystine while being reported to be safe against canine kidney and mouse fibroblast cells. Thus, the synthesis of such a facile molecule aimed at the dual management of cystinuria and related infections is unprecedented in the literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CystinuriaBacterial InfectionsMiceAnimalsDogsTioproninCystineDisulfidesEscherichia coliNitric Oxide

Stichwörter der Autor:innen

antibacterialbiofilmcystinuriadual managementpreventiontiopronin-NO

Substanzen

TioproninCystineDisulfidesNitric Oxide

Autor:innen und Institutionen

  • School of Chemical Materials and Biomedical Engineering, University of Georgia, Athens, Georgia 30602, United States.
  • Pharmaceutical and Biomedical Sciences Department, College of Pharmacy, University of Georgia, Athens, Georgia 30602, United States.

ORCID-Profile: Mark Richard Stephen Garren, Hitesh Handa

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Kumar, A., Estes Bright, L. M., Garren, M. R. S., Manuel, J., Shome, A., & Handa, H. (2023). Chemical Modification of Tiopronin for Dual Management of Cystinuria and Associated Bacterial Infections. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c07160

Vancouver

Kumar A, Estes Bright LM, Garren MRS, Manuel J, Shome A, Handa H. Chemical Modification of Tiopronin for Dual Management of Cystinuria and Associated Bacterial Infections. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c07160

BibTeX
@article{Kumar2023,
  author = {Kumar, Anil and Estes Bright, Lori M and Garren, Mark Richard Stephen and Manuel, James and Shome, Arpita and Handa, Hitesh},
  title = {Chemical Modification of Tiopronin for Dual Management of Cystinuria and Associated Bacterial Infections},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c07160}
}
Kostenlos starten →